Medical Device Industry News

MassDevice.com +3 | The top 3 medtech stories for July 28, 2014

July 28, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Exclusive: IRS collected $1.4B in medtech excise tax payments in 2013

July 28, 2014 by Brian Johnson

The IRS calculates that medtech companies paid the federal government $1.4 billion in medical device excise taxes in 2013, according to a response to a Freedom of Information Act request by MassDevice.com.

MassDevice.com coverage of the medical device tax

Medical device companies ponied up $1.4 billion in excise tax payments to the federal government in 2013 to pay for Obamacare, according to documents supplied to MassDevice.com by the Internal Revenue Service.

Augmenix raises $11M for surgical hydrogels as Varian's purchase option expires

July 28, 2014 by Arezu Sarvestani

Varian passes on an acquisition option as Augmenix closes a Series D funding round with $10.8 million raised in support of its Space OAR hydrogel for protecting the rectum during prostate radiation therapy.

Augmenix raises $11M for surgical hydrogels

Massachusetts-based Augmenix is hoping it can make it to the U.S. market with the $10.8 million funding round it just closed, the company said this month.

ResMed kicks Apex sleep masks out of Germany

July 28, 2014 by Arezu Sarvestani

ResMed lands a permanent injunction barring rival Apex Medical from selling sleep-respiratory products that include headgear found to infringe on ResMed's patents.

ResMed kicks Apex out of Germany for good

Arch-rivals ResMed (NYSE:RMD) and Apex Medical each tallied wins this month in the long-running battle over sleep-base respiratory technologies, but ResMed took the lead with a German court decision to permanently bar certain Apex products.

Michigan judge shoots down settlement alleged by Biomet in poaching spat with Stryker | Medtech legal news for the week of July 28, 2014

July 28, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Judge nixes alleged settlement in Stryker, Biomet poaching spat; Boston Scientific loses bids to exclude testimony in pelvic mesh trials; Occlutech claims another win over St. Jude Medical; Align Tech declares a 'total win' as federal circuit reverses ITC ruling; Report: Medtronic shareholder sues to block Covidien merger

Judge nixes alleged settlement in Stryker, Biomet poaching spat

July 23, 2014 by Brad Perriello

Guided Therapeutics finally re-files PMA for cervical scanner

July 28, 2014 by Arezu Sarvestani

After 2 failed attempts at FDA approval, Guided Therapeutics returns with an amended application for its LuViva cervical scanner.

Guided Therapeutics finally re-files PMA for cervical scanner

Medtronic pays up to $105 million for Visualase

July 28, 2014 by Brad Perriello

Medtronic says it will pay up to $105 million to acquire Visualase and its MRI-guided neurosurgery laser device.

Medtronic pays up to $105 million for Visualase

Medtronic (NYSE:MDT) said today that it paid up to $105 million to acquire Visualase and its MRI-guided laser neurosurgery device.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp